Related Experiment Video
Updated: May 27, 2026

An In Vitro Model of a Parallel-Plate Perfusion System to Study Bacterial Adherence to Graft Tissues
Published on: January 7, 2019
Prosthetic valve endocarditis: what is the evidence for anticoagulant therapy?
1Department of Medicine, University of Melbourne, St Vincent's Hospital, Melbourne, Victoria, Australia. jwyau@unimelb.edu.au
Abstract:
The use of anticoagulant therapy in prosthetic valve endocarditis is a controversial management issue. Some authorities believe that anticoagulation increases the potential risk of cerebral haemorrhage after a thromboembolism whereas others, however, affirm that cessation of anticoagulation itself increases the risk of thromboembolism and subsequent morbidity and mortality. We reviewed the association of anticoagulant therapy and cerebral complications in patients with prosthetic valve endocarditis. Our results suggest that anticoagulant therapy reduces the risk of thromboembolism and is not associated with increased risk of intracranial haemorrhage.
Related Concept Videos
Endocarditis III: Medical Management
Endocarditis I: Introduction
Venous Thrombosis III: Interprofessional Care
Endocarditis IV: Nursing Management
Endocarditis II: Clinical Features of Infective Endocarditis
Mitral Stenosis III: Medical Management